欧普康视(300595) - 2021 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2021 was ¥425,991,350.48, representing a 37.61% increase year-over-year[4] - Net profit attributable to shareholders for Q3 2021 was ¥186,994,921.86, up 25.02% compared to the same period last year[4] - For the first three quarters of 2021, total revenue reached ¥996,129,093.67, a 64.22% increase year-over-year[8] - The net profit attributable to shareholders for the first three quarters was ¥442,962,944.79, reflecting a 59.63% growth compared to the previous year[8] - Total operating revenue for Q3 2021 reached ¥996,129,093.67, a significant increase of 64.2% compared to ¥606,596,719.70 in the same period last year[24] - Net profit for Q3 2021 was ¥476,342,514.11, up 67.2% from ¥284,952,315.46 in Q3 2020[26] - Basic earnings per share increased to ¥0.5222, compared to ¥0.3273 in the previous year, reflecting a growth of 59.5%[27] Cash Flow and Liquidity - The company's cash flow from operating activities for the first three quarters was ¥496,148,435.26, an increase of 95.55% year-over-year[5] - Cash inflows from operating activities totaled ¥1,059,693,636.57, a 68.55% increase from ¥628,714,620.17, mainly due to higher sales revenue and increased collection of receivables[13] - Cash flow from operating activities was ¥1,047,785,061.92, compared to ¥620,699,571.31 in the same period last year, representing a growth of 68.9%[28] - Net cash flow from operating activities reached CNY 496,148,435.26, compared to CNY 253,713,164.64 in the same period last year, indicating a year-over-year increase of 95.5%[29] - The company reported a net increase in cash and cash equivalents of CNY 592,008,683.27, compared to CNY 94,854,467.46 in the previous year, showing a substantial increase of 523.5%[30] Assets and Liabilities - Total assets as of September 30, 2021, were ¥2,848,995,281.08, a 28.74% increase from the end of the previous year[5] - The company's total assets reached ¥2,848,995,281.08, up from ¥2,212,923,975.75, indicating a growth of 28.7%[23] - Total liabilities as of Q3 2021 amounted to ¥458,905,703.20, a 106.7% increase from ¥221,735,346.69 in the same period last year[23] - The company’s total liabilities increased to CNY 243,591,838.24 from CNY 209,819,798.92, reflecting a rise of 16.1%[35] - The total non-current liabilities were CNY 11,915,547.77, reflecting a strategic management of long-term obligations[36] Investment and Growth - Investment income surged by 147.15% to ¥61,245,769.25 from ¥24,780,888.14, attributed to gains from the transfer of subsidiary equity and increased returns from idle funds[12] - The significant increase in investment cash inflow suggests a robust investment strategy and potential for future growth[30] - The company’s long-term equity investments rose to RMB 167.55 million, up from RMB 75.51 million at the end of 2020, marking an increase of approximately 121%[20][21] Research and Development - R&D expenses rose by 51.09% to ¥20,560,255.26 from ¥13,608,300.55, reflecting increased investment in research and development[12] - Research and development expenses for Q3 2021 were ¥20,560,255.26, an increase of 51.1% from ¥13,608,300.55 in Q3 2020[25] Shareholder Information - The total number of common shareholders at the end of the reporting period was 44,619, with the largest shareholder holding 35.14% of the shares[14] - The company reported a total of CNY 988,376,516.00 in undistributed profits, contributing to a total equity attributable to shareholders of CNY 1,751,983,461.21[36] Other Financial Metrics - The company experienced a 60.14% increase in income tax expenses, amounting to ¥78,545,205.97, correlating with the rise in profits[12] - The total cost of operations for Q3 2021 was ¥507,492,351.31, which is a 71.6% increase from ¥295,574,405.62 in the previous year[25] - The company has not audited its third-quarter report, which may affect investor confidence in the reported figures[38]